Dal-Yong Gwak

Title: Dal-Yong Gwak: Innovator in Pharmaceutical Compounds

Introduction

Dal-Yong Gwak is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases.

Latest Patents

Dal-Yong Gwak holds a patent for "1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same." This invention relates to novel compounds that exhibit histone deacetylase 6 (HDAC6) inhibitory activity. The compounds, including their stereoisomers and pharmaceutically acceptable salts, are designed for therapeutic use in treating various diseases. These diseases include infectious diseases, neoplasms, metabolic disorders, neurological diseases, and more. The patent outlines methods for preparing these compounds and their application in pharmaceutical compositions.

Career Highlights

Dal-Yong Gwak is associated with Chong Kun Dang Pharmaceutical Corporation, where he continues to innovate in the pharmaceutical sector. His work focuses on developing effective treatments for a range of health conditions through novel chemical compounds.

Collaborations

Dal-Yong Gwak collaborates with talented individuals such as Jaekwang Lee and Yuntae Kim. Their combined expertise contributes to the advancement of pharmaceutical research and development.

Conclusion

Dal-Yong Gwak's contributions to pharmaceutical innovations highlight the importance of research in developing effective treatments for various diseases. His work exemplifies the impact of inventive thinking in the medical field.